International Journal of Cancer Research & Therapy(IJCRT)
ISSN: 2476-2377 | DOI: 10.33140/IJCRT
Impact Factor: 1.3
Carlos Alfonso Duarte-Torres
Specialist in Oncological Surgery, Functional Unit for Breast and Soft Tissue Tumors, Instituto Nacional de Cancerologia, Bogota, Colombia
Publications
-
Research Article
Is Sentinel Lymph Node Tumor Burden a Prognostic Factor for Disease-Free Survival in Patients with Melanoma of the Trunk and Extremities?
Author(s): Carlos Lehmann-Mosquera, Raul Suarez-Rodriguez*, Patricia Lopez-Correa, Ricardo Sanchez, Samuel David Morales, Mauricio Garcia-Mora, Javier Angel-Aristizabal, Ivan Marino-Lozano, Carlos Alfonso Duarte-Torres and Sandra E. Di-az-Casas
Introduction Sentinel lymph node (SLN) involvement in patients with melanoma is the most important prognostic factor and is decisive for the indication of adjuvant systemic therapy. Scientific evidence shows that SLN tumor burden is a prognostic factor for disease- free survival. Methods A descriptive observational historical cohort study was conducted, which included patients diagnosed with melanoma of the trunk and extremities who underwent SLN biopsy in the Functional Unit for Breast and Soft Tissue Tumors at the Instituto Nacional de Cancerología (Bogotá, Colombia). The clinical characteristics were described, with a review by pathology of the size of lymph node metastasis and extracapsular extension in the histological plate of each included patient. The analyses were performed with the statistical program Stata 16®... Read More»